TP53 and urinary bladder cancer: Although GSK-3β depletion had little effect on viability of p53-null HCT116p53KO colon cancer cells and p53-mut HT1376 bladder cancer cells, it restored the sensitivity of these cells to DNA-damaging agents, such as 5-FU.